Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

How Brooklinen Went From Kickstarter to $20M in Sales
51:17 - Brooklinen co-founders Rich and Vicki Fulop launched the bedding retailer from Brooklyn in 2014. A Kickstarter campaign brought in nearly $250,000 and set the stage for growth to over $20 million in sales in 2016. CEO Rich Fulop discusses the trajectory in this edition of "Small to Big." (Source: Bloomberg)
  • QuickTake: The Rise of Hamas
  • EX-CIA Director Says 'Nothing Easy' About Terror Fight
  • Manchester Attack Puts U.K. Campaigning on Hold